PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[x1power]

You do make some sense with your hypothesis, as the company does not seem to have funds available for sales assistance direct to patients and their doctors. This can happen quite often with small innovative companies, they just go to conferences and expect everyone to flock to their table. Need to give away samples?

Not happy that stock price is crashing back to support range.
Still believe in company, however can indeed the company withstand
the apparent lack of acceptance of their novel bio-tech by the huge giants of treatment? Is it not ever so for tiny unique product/service companies?

I have noted that techies in foreign companies do have problems relating to worldwide marketing in USA.

As another poster has noted, Sometimes it seems bio-techs are like small EV or solar cell companies , e.g. is a longer-shot hold company on buy-out potentials. The one real possibility for this company is eventually smart patients will demand their doctors get them some samples to try as animal-based drugs DO NOT help their conditions.